LE WE PMID CA
Dasatinib4309Dasatinib

Biologicals (Adverse effects)

Dasatinib

Imatinib

Leukemia (chronic myeloic)

Nilotinib

2009  
1
Dasatinib in chronic myeloid leukemia: a review.
[19536317] Ther Clin Risk Manag 5(2): 281-9 (2009)
2007  
2
Dasatinib: a new step in molecular target therapy.
[17591830] Ann Oncol 18 Suppl 6(-): vi42-6 (2007)
2009  
3
Dasatinib treatment for Philadelphia chromosome-positive leukemias: practical considerations.
[19195046] Cancer 115(7): 1381-94 (2009)
2010  
4
First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib.
[21108851] J Hematol Oncol 3(-): 47 (2010)
2009  
5
The occurrence and management of fluid retention associated with TKI therapy in CML, with a focus on dasatinib.
[19909541] J Hematol Oncol 2(-): 46 (2009)
2011  
6
Moving on up: Second-Line Agents as Initial Treatment for Newly-Diagnosed Patients with Chronic Phase CML.
[21792346] Clin Med Insights Oncol 5(-): 185-99 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.



  • Dasatinib

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia